AAAAAA

   
Results: 1-8 |
Results: 8
A synthetic pentasaccharide for the prevention of deep-vein thrombosis
Authors: Landow, L
Citation: L. Landow, A synthetic pentasaccharide for the prevention of deep-vein thrombosis, N ENG J MED, 345(4), 2001, pp. 291-292
Current issues in clinical trial design - Superiority versus equivalency studies
Authors: Landow, L
Citation: L. Landow, Current issues in clinical trial design - Superiority versus equivalency studies, ANESTHESIOL, 92(6), 2000, pp. 1814-1820
Low-molecular weight heparin, spinal hematomas, and the FDA: What's wrong with this picture?
Authors: Landow, L Bedford, RA
Citation: L. Landow et Ra. Bedford, Low-molecular weight heparin, spinal hematomas, and the FDA: What's wrong with this picture?, REG ANES PA, 24(1), 1999, pp. 8-10
FDA approves drugs even when experts on its advisory panels raise safety questions
Authors: Landow, L
Citation: L. Landow, FDA approves drugs even when experts on its advisory panels raise safety questions, BR MED J, 318(7188), 1999, pp. 944-944
Off-label use of approved drugs
Authors: Landow, L
Citation: L. Landow, Off-label use of approved drugs, CHEST, 116(3), 1999, pp. 589-591
FDA's role in anesthetic drug development
Authors: Landow, L Kahn, RC Wright, C
Citation: L. Landow et al., FDA's role in anesthetic drug development, ANESTHESIOL, 90(3), 1999, pp. 882-889
Monitoring adverse drug events: The Food and Drug Administration MedWatch reporting system
Authors: Landow, L
Citation: L. Landow, Monitoring adverse drug events: The Food and Drug Administration MedWatch reporting system, REG ANES PA, 23(6), 1998, pp. 190-193
Financial disclosure is needed at the lectern, as well as in print
Authors: Landow, L
Citation: L. Landow, Financial disclosure is needed at the lectern, as well as in print, CRIT CARE M, 26(12), 1998, pp. 2093-2093
Risultati: 1-8 |